Clinical Trials Directory

Trials / Completed

CompletedNCT01252979

Ketones & Mitochondrial Heteroplasmy

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
13 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The current study is a prospective evaluation of the ability of ketosis to shift mitochondrial DNA (mtDNA) heteroplasmy in subjects harboring a known mutation in their mtDNA at position 3243 (A\>G). Subjects will be given supplemental medium chain triglycerides (MCTs) for a period of 6 months. mtDNA heteroplasmy will be measured 3 months prior to treatment, at treatment initiation, and 6 months after initiation. The primary objective of the current study is to determine if there is a shift in heteroplasmy in patients harboring the 3243 A\>G mtDNA mutation to a more favorable (higher wild-type) profile while in a state of ketosis.

Detailed description

The current study is a prospective evaluation of the ability of ketosis to shift mitochondrial DNA (mtDNA) heteroplasmy in subjects harboring a known pathogenic mutation in their mtDNA at position 3243 (A\>G). Subjects will be induced in to ketosis by administration of supplemental medium chain triglycerides (MCTs) for a period of 6 months. mtDNA heteroplasmy will be assessed 3 months prior to treatment, at treatment initiation, and 6 months after initiation. The primary objective of the current study is to determine if there is a shift in heteroplasmy in patients harboring the 3243 A\>G mtDNA mutation to a more favorable (higher wild-type) genotypic profile while in a state of ketosis.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMedium-Chain TriglyceridesSubjects will take supplemental MCT oil 3 times a day for 6 months

Timeline

Start date
2010-12-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2010-12-03
Last updated
2012-02-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01252979. Inclusion in this directory is not an endorsement.